webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-3VVD-OH

  CAS No.: 863971-44-2   Cat No.: BADC-00695   Purity: ≥95% 4.5  

Fmoc-3VVD-OH is a protected amino acid derivative for peptide-based ADC linker synthesis, enabling controlled conjugation and enhanced stability of antibody-drug conjugates.

Fmoc-3VVD-OH

Structure of 863971-44-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C36H51N3O7
Molecular Weight
637.81
Shipping
Room temperature
Shipping
Store at 2-8°C, stored under nitrogen

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(5S,9S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,9-diisopropyl-12-methoxy-4,10-dimethyl-3,6,8-trioxo-2-oxa-4,7,10-triazatetradecan-14-oic acid; N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-valyl-N-[(2R,3S,4S)-1-carboxy-2-methoxy-4-methyl-3-hexanyl]-N-methyl-L-valinamide; L-Valinamide, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-valyl-N-[(1S,2S)-1-[(1R)-2-carboxy-1-methoxyethyl]-2-methylbutyl]-N-methyl-; FMOC-3AA-OH
IUPAC Name
(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methoxy-5-methylheptanoic acid
Canonical SMILES
CCC(C)C(C(CC(=O)O)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13
InChI
InChI=1S/C36H51N3O7/c1-10-23(6)33(29(45-9)19-30(40)41)38(7)35(43)31(21(2)3)37-34(42)32(22(4)5)39(8)36(44)46-20-28-26-17-13-11-15-24(26)25-16-12-14-18-27(25)28/h11-18,21-23,28-29,31-33H,10,19-20H2,1-9H3,(H,37,42)(H,40,41)/t23-,29+,31-,32-,33-/m0/s1
InChIKey
SMVBIYSFDNRJJI-FCUBIXSHSA-N
Density
1.1±0.1 g/cm3
Solubility
Soluble in DMSO
Shipping
Room temperature
Storage
Store at 2-8°C, stored under nitrogen
Boiling Point
793.0±60.0°C at 760 mmHg

Fmoc-3VVD-OH, a fluorenylmethyloxycarbonyl (Fmoc) protected amino acid derivative, plays a pivotal role in peptide synthesis and biochemical research. Here are four key applications of Fmoc-3VVD-OH:

Peptide Synthesis: Essential in solid-phase peptide synthesis (SPPS), Fmoc-3VVD-OH facilitates the precise assembly of intricate peptide chains. The Fmoc group shields the amino terminal, safeguarding against undesirable reactions during synthesis. This meticulous process ensures the synthesis of peptides with pristine purity and accuracy, critical for a myriad of biochemical and pharmaceutical investigations.

Drug Development: Leveraging Fmoc-3VVD-OH within peptide libraries is instrumental in the exploration of novel therapeutic peptides possessing drug-like attributes. Researchers can design and evaluate diverse peptide sequences to screen for biological activity, binding affinity, and stability. This methodology expedites the identification and refinement of peptide-based drugs aimed at combating various diseases,.

Protein Engineering: In the realm of protein engineering, Fmoc-3VVD-OH is deployed to craft modified peptides and proteins endowed with distinctive properties and functions. By integrating this specific amino acid derivative into protein sequences, researchers introduce a spectrum of structural and functional diversity. These tailored proteins serve as invaluable tools for probing protein interactions, stability, and functionality across diverse biological contexts, enriching our understanding of protein behavior.

Bioconjugation: Fmoc-3VVD-OH plays a pivotal role in the development of peptide conjugates that link peptides to other molecules like drugs, probes, or nanoparticles. This conjugation enhances the specificity, delivery, and efficacy of therapeutic agents and diagnostic tools. Bioconjugates formulated with Fmoc-3VVD-OH find application in targeted drug delivery, imaging techniques, and biosensor technologies.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: 4-Methyl-4-(pyridin-2-yldisulfanyl)pentanoic acid | N-(2-(2-Ethylphenoxy)ethyl)-4-Formylbenzamide | Me-Tet-PEG4-NHS | DBCO-NH-PEG4-amine | Propargyl-PEG7-acid | 2,5-dioxopyrrolidin-1-yl 4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoate | 3-azidopropanoate-N-hydroxysuccinimide ester | NHPI-PEG3-C2-PFP ester | 4-nitrophenyl 2-(pyridin-2-yldisulfanyl)propyl carbonate | Fmoc-Gly-Gly-Phe-OtBu | NHPI-PEG3-C2-NHS ester
Send Inquiry
Verification code
Inquiry Basket